Adaptive Biotechnologies ADPT reported its Q4 earnings results on Wednesday, February 14, 2024 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
Adaptive Biotechnologies reported in-line EPS of $-0.3 versus an estimate of $-0.3.
Revenue was down $9.41 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.01 which was followed by a 18.18% drop in the share price the next day.
Here's a look at Adaptive Biotechnologies's past performance:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.34 | -0.33 | -0.38 | -0.35 |
| EPS Actual | -0.35 | -0.33 | -0.40 | -0.28 |
| Revenue Estimate | 42.96M | 45.48M | 36.81M | 55.27M |
| Revenue Actual | 37.92M | 48.93M | 37.65M | 55.20M |
To track all earnings releases for Adaptive Biotechnologies visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
